Correction: Inhibition of EHMT2/G9a epigenetically increases the transcription of Beclin-1 via an increase in ROS and activation of NF-κB (Oncotarget (2016) 7 (39796-39808) DOI: 10.18632/oncotarget.92900)

Sang Eun Park, Hye Jin Yi, Nayoung Suh, Yun Yong Park, Jae Young Koh, Seong Yun Jeong, Dong Hyung Cho, Choung Soo Kim, Jung Jin Hwang

Research output: Contribution to journalComment/debate

2 Scopus citations

Abstract

This article has been corrected: Due to errors during data processing, partial duplication occurred between Figures 2c, 2e and 4b. In addition, typing errors were made within Figure 6e and Supplemental 4a. In Figure 6e, the correlation coefficient (r value) in the picture is -0.177. In the original picture, the '-' is missing. In Supplementary figure 4a, the labeling of BECN-1 and EHMT2 were reversed. The authors declare that these corrections do not change the results or conclusions of this paper. (Figure Presented).

Original languageEnglish
Pages (from-to)4348-4349
Number of pages2
JournalOncotarget
Volume10
Issue number42
DOIs
StatePublished - 2019

Fingerprint

Dive into the research topics of 'Correction: Inhibition of EHMT2/G9a epigenetically increases the transcription of Beclin-1 via an increase in ROS and activation of NF-κB (Oncotarget (2016) 7 (39796-39808) DOI: 10.18632/oncotarget.92900)'. Together they form a unique fingerprint.

Cite this